Phase 2 × Terminated × Surgical Procedures, Operative × Clear all NBI-CAB
Phase 2 Terminated
23 enrolled
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Phase 2 Terminated
90 enrolled 24 charts
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Phase 2 Terminated
5 enrolled 11 charts
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Phase 2 Terminated
8 enrolled 11 charts
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients
Phase 2 Terminated
10 enrolled
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Terminated
35 enrolled
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Phase 2 Terminated
12 enrolled
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 9 charts
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
Phase 2 Terminated
8 enrolled 9 charts
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Phase 2 Terminated
22 enrolled 11 charts
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase 2 Terminated
7 enrolled 8 charts
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Terminated
4 enrolled 4 charts
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
Phase 2 Terminated
6 enrolled 4 charts
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
Phase 2 Terminated
3 enrolled
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
Phase 2 Terminated
22 enrolled 10 charts
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
Phase 2 Terminated
5 enrolled 6 charts
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Phase 2 Terminated
8 enrolled 5 charts
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Terminated
6 enrolled 8 charts
TOP0901
Phase 2 Terminated
6 enrolled 6 charts
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
Phase 2 Terminated
30 enrolled
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Phase 2 Terminated
Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Phase 2 Terminated
1 enrolled
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
Phase 2 Terminated
13 enrolled
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Phase 2 Terminated
73 enrolled
Radiation Therapy With Capecitabine in Rectal Cancer
Phase 2 Terminated
30 enrolled